Statistical flag only — not an accusation of fraud
⚠️ This provider averages 1.9K services per working day — physically unusual for an individual practitioner
Based on 4.8M total services over 10 years (250 working days/year). Learn about impossible service volumes →
This provider's $54.5M in total Medicare payments ranks in the 99th percentile of Hematology-Oncology providers nationally.
Averaging 1.9K services per working day raises questions about billing patterns.
This provider has been statistically flagged with a risk score of 68/100. Statistical flags are not accusations of fraud.
AI-generated analysis based on Medicare payment data.
Notable: Payments increased 120% in 2018
Year-over-year payment surges can indicate changes in practice volume, new services, or billing pattern shifts.
Average per-service amounts submitted by the provider compared to what Medicare actually paid — the gap represents the markup.
| Year | Avg Submitted | Avg Paid | Markup Ratio | Gap per Service | Total Payments | Services | Beneficiaries |
|---|---|---|---|---|---|---|---|
| 2014 | $55.33 | $12.02 | 4.60x | $43.31 | $3.3M | 278.4K | 57 |
| 2015 | $46.76 | $9.62 | 4.86x | $37.14 | $3.8M | 398.5K | 60 |
| 2016 | $43.47 | $9.35 | 4.65x | $34.12 | $4.4M | 473.4K | 59 |
| 2017 | $42.90 | $8.24 | 5.21x | $34.66 | $3.9M | 476.8K | 62 |
| 2018 | $46.44 | $10.82 | 4.29x | $35.62 | $8.7M | 800.3K | 84 |
| 2019 | $56.39 | $13.93 | 4.05x | $42.46 | $8.8M | 631.4K | 82 |
| 2020 | $52.11 | $13.24 | 3.94x | $38.87 | $7.9M | 598.8K | 76 |
| 2021 | $51.74 | $12.52 | 4.13x | $39.22 | $5.8M | 460.1K | 67 |
| 2022 | $41.32 | $9.22 | 4.48x | $32.10 | $3.7M | 404.0K | 63 |
| 2023 | $52.01 | $12.67 | 4.10x | $39.34 | $4.1M | 325.6K | 58 |
| Code | Description | Services | Payments | Avg/Service | Markup |
|---|---|---|---|---|---|
| J9271 | Injection, pembrolizumab, 1 mg | 198.6K | $8.1M | $40.85 | 2.87x |
| J9299 | Injection, nivolumab, 1 mg | 232.9K | $5.0M | $21.54 | 2.93x |
| J9035 | Injection, bevacizumab, 10 mg | 75.8K | $4.3M | $56.48 | 2.51x |
| J2505 | Injection, pegfilgrastim, 6 mg | 1.1K | $3.6M | $3.2K | 2.98x |
| J9310 | Injection, rituximab, 100 mg | 3.9K | $2.3M | $598.07 | 2.42x |
| J0897 | Injection, denosumab, 1 mg | 152.0K | $2.2M | $14.55 | 2.91x |
| J9355 | Injection, trastuzumab, 10 mg | 28.8K | $2.1M | $74.46 | 2.42x |
| J9264 | Injection, paclitaxel protein-bound particles, 1 mg | 184.8K | $1.6M | $8.63 | 3.45x |
| J9395 | Injection, fulvestrant, 25 mg | 27.7K | $1.6M | $57.21 | 3.82x |
| 96413 | Administration of chemotherapy into vein, 1 hour or less | 16.4K | $1.6M | $94.35 | 8.02x |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | 19.3K | $1.5M | $79.33 | 3.77x |
| J9305 | Injection, pemetrexed, not otherwise specified, 10 mg | 28.7K | $1.5M | $51.04 | 2.58x |
| J1569 | Injection, immune globulin, (gammagard liquid), non-lyophilized, (e.g., liquid), 500 mg | 41.8K | $1.4M | $33.56 | 5.00x |
| Q5115 | Injection, rituximab-abbs, biosimilar, (truxima), 10 mg | 22.5K | $1.1M | $46.79 | 4.52x |
| J9041 | Injection, bortezomib (velcade), 0.1 mg | 28.5K | $1.0M | $35.95 | 3.02x |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | 19.5K | $980.9K | $50.20 | 4.00x |
| J9173 | Injection, durvalumab, 10 mg | 14.2K | $862.4K | $60.92 | 2.97x |
| J9022 | Injection, atezolizumab, 10 mg | 13.5K | $825.2K | $61.13 | 3.03x |
| J0885 | Injection, epoetin alfa, (for non-esrd use), 1000 units | 97.8K | $822.7K | $8.41 | 4.38x |
| J1930 | Injection, lanreotide, 1 mg | 16.9K | $810.0K | $47.87 | 2.70x |
This provider submits charges 4.34 times higher than what Medicare actually pays.
A markup ratio of 4.34x means for every $100 Medicare pays, this provider initially charges $434. This is higher than the national average.
Always verify provider credentials and location before scheduling appointments. This data reflects Medicare payments and may not include all practice locations.
Other Hematology-Oncology providers in AR for peer comparison.
| Provider | Location | Total Payments | Status |
|---|---|---|---|
| Kamal Patel, M.D. | Little Rock, AR | $58.7M | ⚠️ Flagged |
| Eric Schaefer, M.D. | Fayetteville, AR | $35.5M | ✓ Clear |
| Thomas Sneed, M.D. | Little Rock, AR | $34.7M | ✓ Clear |
| Lawrence Mendelsohn, MD | Little Rock, AR | $34.6M | ⚠️ Flagged |
| Gregory Oakhill, M.D. | Fayetteville, AR | $34.2M | ✓ Clear |
Share this provider's Medicare payment information
Last Updated: February 2026 (data through 2023, the latest CMS release)
Note: All data is from publicly available Medicare records. OpenMedicare is an independent journalism project not affiliated with CMS.
Believe this data is inaccurate? Dispute this data